Drug intelligence / Profile preview

Calafiore cardioplegia

Development stage
Unknown
Lead developer
Antonio Calafiore
Modality
Small Molecules
Administration
Intracoronary
01

Overview

Calafiore cardioplegia is a myocardial protection strategy used during cardiac surgery, most notably in coronary artery bypass grafting (CABG). Developed by surgeon Antonio Calafiore, this technique utilizes intermittent, antegrade (or sometimes retrograde) delivery of a warm (normothermic or tepid) blood-based solution enriched with potassium and magnesium. Unlike traditional cold crystalloid cardioplegia, the Calafiore method leverages the oxygen-carrying capacity of the patient's own blood and avoids the physiological stressors associated with profound hypothermia and hemodilution. The solution induces rapid diastolic cardiac arrest by elevating extracellular potassium concentrations, which depolarizes the cardiomyocyte membrane and inactivates voltage-gated sodium channels. The inclusion of magnesium acts as a natural calcium antagonist, preventing intracellular calcium overload and reducing reperfusion injury. This approach is favored for its simplicity and the maintenance of myocardial metabolic activity during the ischemic period.

Other names
warm blood cardioplegiatepid blood cardioplegiaintermittent warm blood cardioplegiaCalafiore solutionCalafiore microplegiamodified Calafiore cardioplegia
02

Targets

CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)CaV (Voltage-gated calcium channel protein complex)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Calafiore cardioplegia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calafiore cardioplegia.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call